|
Model Number MMT-105NNPKNA |
Device Problems
Insufficient Flow or Under Infusion (2182); Patient Device Interaction Problem (4001); Priming Problem (4040)
|
Patient Problems
Hyperglycemia (1905); Urinary Frequency (2275); Polydipsia (2604)
|
Event Date 04/20/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.The device will be returned for analysis and further information will follow once the analysis has been completed.No conclusion can be drawn at this time.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
Information received by medtronic indicated that the customer reported hyperglycemia with a blood glucose value of 321 mg/dl and reported the priming was not successful.Troubleshooting was performed and found that the inpen was not delivering insulin properly.The customer was hospitalized and treated with an inpen and manual injection and the customer was not reporting any symptoms related to the blood glucose value.The customer was admitted to the hospital on (b)(6) 2020 and experienced symptoms of frequent urination and excessive thirst.The customer also reported screw movement issues and found that the injection foot was touching the plunger inside the cartridge.No further patient complications were reported.The customer will discontinue using the inpen.The inpen will be returned for analysis.
|
|
Manufacturer Narrative
|
Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Information has been corrected which was not correct in the initial report.The information has been provided in this report.
|
|
Event Description
|
Updated summary: customer was not hospitalized due to hyperglycemia.
|
|
Search Alerts/Recalls
|
|
|